[1] 杨永宗, 阮长耿, 唐朝枢,等, 动脉粥样硬化性心血管病·基础与临床[M].北京: 科学出版社, 2004. [2] Stary HC, Chandler AB,Dinsmoe RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Atherosclerosis,American Heart Association secial report[J].Circulation, 1995,92:1355-1374. [3] 邓仲端. 趋化因子在动脉粥样硬化形成和发展中的作用[J].中华病理学杂志, 1998, 27(3):238-239. [4] Ross, Russell, Atheroslerosis an inflammatory disease[J]. N Engl J Med, 1999 340:115-126. [5] Shicong ZHANG, Xiangqun LIU, Huanqin CHEN et al. Effects of Baicalin on the NF-κB and ACE2 protein expression in atherosclerosis of ApoE-/-mice induced by hyperlipaemia[I]. Medicinal Plant, 2013, (8):47-50. [6] Tak PP and Firestein GS. NF-kappaB: a key role in inflammatory diseases[J]. J Clin Invest, 2001, 107:7-11. [7] Qiutang Li, Inder M.Verma NF-[kappa]B regulation in the immune system[J]. Nat Rev Immunol, 2002, 2:725-734. [8] Sen R, Baltimore D, Multiple nuclear factors interact with the immunoglobulin enhancer sequences[J]. Cell, 1986, 46(5): 705-716. [9] Karin M, Ben-Neriah Y Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity[J]. Annu Rev Immunol 2000, 18:621-663. [10] 栗艳婵, 张明升. 通心络胶囊对实验家兔动脉粥样硬化腹主动脉NF-κB的影响[J].临床合理用药, 2011, 4(4):1-2. [11] Kim I, Moon SO, Kim SH, et al.Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM- 1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells[J]. J Cell Biochem, 2001, 276(1):7614-620. [12] Tedgui A, Mallat Z.Cytokines in atherosclerosis: pathogenic and regulatory pathways[J]. Physiol Rev, 2006, 86(2):515-581. |